New-Generation Anaplastic Lymphoma Kinase Inhibitor Experience in a Case With Non-Small Cell Lung Cancer: High Efficacy but Unexpected Toxicity.

Buyuksimsek, Mahmut

New-Generation Anaplastic Lymphoma Kinase Inhibitor Experience in a Case With Non-Small Cell Lung Cancer: High Efficacy but Unexpected Toxicity. [electronic resource] - American journal of therapeutics Mar 2020 - e799-e801 p. digital

Publication Type: Journal Article

1536-3686

10.1097/MJT.0000000000001115 doi